Events
Targeted Therapies: Navigating the Business Challenges of Personalized Medicine and ROI
Tuesday, December 1, 2009
12:00 – 1:30 pm EST
To view the presentation materials, please click here.
To access the archived webcast, please click here.
To view additional materials, please click here.
This program will explore the considerations and challenges innovators and investors face in determining where to direct their resources when looking to contribute to the evolution of personalized medicine tests and therapies. Presenters will offer insights on the following topics:
- Assessing opportunities for investment
- Managing business and legal/regulatory challenges to developing and promoting new products
- Measuring return on investment
- Strategizing to optimize reimbursement
Speakers
Matthew Hudes, National Managing Principal, Biotechnology, Life Sciences & Health Care, Deloitte Consulting LLP
Paul Radensky, M.D., Partner & Co-Chair, Life Sciences Government Strategies, McDermott Will & Emery LLP
This program is the second complimentary webcast in a three-part series, Personalized Medicine: Thriving in a Rapidly Changing World, conducted by McDermott Will & Emery and Deloitte LLP.
Upcoming Webcast
Customizing Care: The Future of Personalized Medicine – Wednesday, January 27, 2010
For more information, please contact McDermott Events.
CLE credit is pending in California, Illinois, New York and Texas. A Uniform Certificate of Attendance will be made available to participants requesting CLE credit in all other states. Click here for more upcoming events.
